Page 2 - Drug Developer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The condition -- characterized by stinging, sensitivity to light, blurred vision and eye fatigue -- affects about 38 million Americans, and is currently treated with over-the-counter artificial tear drops such as GenTeal and Refresh. Prescription eye drops, such as Novartis' Xiidra, AbbVie Inc's Restasis and Sun Pharmaceutical's Cequa are also used to treat dry eye disease. Oyster Point said Tyrvaya, a twice daily nasal spray, was tested in a late-stage and two mid-stage trials covering over 1,000 patients with mild, moderate or severe symptoms of dry eye disease (DED).

If you want to build a career in the Indian clinical research industry, here are a few points you need to know.

Apart from Covishield, the Serum Institute of India (SII) is working on four more vaccines against the novel coronavirus, according to Suresh Jadhav, executive director at one of the world's largest vaccine manufacturers. Jadhav informed during a webinar that the firm has been working on five vaccines against the novel coronavirus, including the Covishield which got approval for emergency use roll-out for mass immunization drive began on Saturday. "For one (vaccine) we have received emergency approval, three others are in different stages of clinical studies while one is in the pre-clinica...

Drug developer and some women's groups. they are accusing the fda of gender bias and 257 other drugs out there to help men but they haven't approved one for women. one drug has been rejected twice. it's going to be reviewed again on thursday. a new treat for "50 shades of grey" fans. the author of the popular erotic novel announced her next book will be coming out next month. can't wait. this will be simply titled "grey." do what works. it tells a story from christian grey's point of view. the author e.l. janes is releasing the book on june 18th to coincide with christian's birthday. didn't kn...